Tag: inclisiran

ACC 2017: Positive final results from ORION-1 phase II study of inclisiran

The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORI...

The Medicines Company announces positive 180-day results for PCSK9 inhibitor

The Medicines Company has announced positive top-line results from the interim analysis with 180-day...